98 related articles for article (PubMed ID: 1322327)
1. [Inhibition of the enzyme of conversion and cardioprotection: role of bradykinins].
Unger T; Lebrun CJ
Diabete Metab; 1992; 18(2 Pt 2):161-9. PubMed ID: 1322327
[TBL] [Abstract][Full Text] [Related]
2. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
Linz W; Schölkens BA
Br J Pharmacol; 1992 Apr; 105(4):771-2. PubMed ID: 1324047
[TBL] [Abstract][Full Text] [Related]
3. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
Bao G; Gohlke P; Qadri F; Unger T
Hypertension; 1992 Jul; 20(1):74-9. PubMed ID: 1319960
[TBL] [Abstract][Full Text] [Related]
4. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
Linz W; Gohlke P; Unger T; Schölkens BA
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T
J Hypertens Suppl; 1992 Aug; 10(6):S141-4. PubMed ID: 1432317
[TBL] [Abstract][Full Text] [Related]
6. Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin.
O'Sullivan JB; Harrap SB
Hypertension; 1995 Feb; 25(2):162-5. PubMed ID: 7843764
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Gohlke P; Linz W; Schölkens BA; Kuwer I; Bartenbach S; Schnell A; Unger T
Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and antihypertensive activities of the novel non-sulfhydryl converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
Schölkens BA; Becker RH; Kaiser J
Arzneimittelforschung; 1984; 34(10B):1417-25. PubMed ID: 6097268
[TBL] [Abstract][Full Text] [Related]
9. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
[TBL] [Abstract][Full Text] [Related]
10. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
[TBL] [Abstract][Full Text] [Related]
11. Role of bradykinin in the reduction of left ventricular hypertrophy induced by angiotensin-converting enzyme inhibitors in spontaneously hypertensive rats.
Sugimoto K; Fujimura A
Jpn J Pharmacol; 1998 Apr; 76(4):431-4. PubMed ID: 9623722
[TBL] [Abstract][Full Text] [Related]
12. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
Bao G; Gohlke P; Unger T
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
[TBL] [Abstract][Full Text] [Related]
13. Kinin contribution to chronic antihypertensive actions of ACE-inhibitors in hypertensive rats.
Bao G; Gohlke P; Unger T
Agents Actions Suppl; 1992; 38 ( Pt 2)():423-30. PubMed ID: 1334342
[TBL] [Abstract][Full Text] [Related]
14. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Linz W; Schölkens BA; Ganten D
Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
[TBL] [Abstract][Full Text] [Related]
15. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
[TBL] [Abstract][Full Text] [Related]
16. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.
Unger T; Mattfeldt T; Lamberty V; Bock P; Mall G; Linz W; Schölkens BA; Gohlke P
Hypertension; 1992 Oct; 20(4):478-82. PubMed ID: 1328047
[TBL] [Abstract][Full Text] [Related]
17. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
[TBL] [Abstract][Full Text] [Related]
18. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
19. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
Unger T; Fleck T; Ganten D; Lang RE; Rettig F
Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
[TBL] [Abstract][Full Text] [Related]
20. The influence of ramipril on blood pressure, ACE-activity, sperm density and motility of spontaneously hypertensive rats during puberty.
Hilse H; Siems WE; Heder G; Stahl F; Jentzsch KD
Pharmazie; 1991 May; 46(5):360-1. PubMed ID: 1832776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
